Article thumbnail

Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients

By Stine Elkjaer Nielsen, Takeshi Sugaya, Peter Hovind, Tsuneharu Baba, Hans-Henrik Parving and Peter Rossing
Topics: Original Research
Publisher: American Diabetes Association
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1996). Cellular fatty acid-binding proteins: their function and physiological significance. Prog Lipid Res
  2. Clinical evaluation of urinary excretion of liver-type fatty acidbinding protein as a marker for the monitoring of chronic kidney disease: a multicenter trial.
  3. Decreased urinary concentration of Tamm-Horsfall protein is associated with development of renal failure andcardiovasculardeathwithin20yearsin type 1 but not in type 2 diabetic patients.
  4. (2003). Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care
  5. (2008). Diabetic nephropathy.
  6. (2005). Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy. Diabetes Care
  7. (2010). Fattyacid-binding proteins do not protect against induced cytotoxicity in a kidney cell model.
  8. GraaeM,TorpI,BinderC,ParvingHH.Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study.
  9. (1992). Molecular identification of the liver- and the hearttypefattyacid-bindingproteinsinhuman and rat kidney. Use of the reverse transcriptase polymerase chain reaction.
  10. (2009). Tubular and glomerular injury in diabetes and the impact of ACE inhibition. Diabetes Care
  11. Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules.
  12. Urinary excretion of liver type fatty acid bindingproteinaccuratelyreflectsthedegree of tubulointerstitial damage.
  13. (2009). Urinary excretion of liver-type fatty acid binding protein (L-FABP) as a useful predictor of future renal in dysfunction